Picard Medical is trading 6.2% lower at $10.64 in pre-market on October 13, with no clear overnight company-specific catalyst identified. - Shares closed at $11.34 on October 12, after rising 19.62% in the prior session. - On October 9, a shareholder-law-firm investigation publicized allegations from an existing complaint; this does not establish the cause of the current decline. - The broader healthcare sector is up 1.58% pre-market, so sector weakness does not explain the drop; evidence points to an unclear stock-specific move.